Patients | Events | 10-year survival % (95% CI) | 15-year survival % (95% CI) | 20-year survival % (95% CI) | p-value | |
Overall survival# | ||||||
Severe | ||||||
NBS | 95 | 23 | 98.84 (92.03–99.84) | 92.56 (84.17–96.59) | 84.93 (74.29–91.41) | 0.007§ |
Symptoms | 34 | 21 | 87.88 (70.86–95.27) | 72.73 (54.13–84.77) | 63.64 (44.95–77.46) | |
Moderate | ||||||
NBS | 80 | 4 | 100.00 | 98.46 (89.58–99.78) | 94.48 (83.72–98.20) | 0.016§ |
Symptoms | 40 | 12 | 100.00 | 88.89 (73.05–95.68) | 85.93 (69.41–93.89) | |
Mild | ||||||
NBS | 149 | 6 | 99.29 (95.07–99.90) | 99.29 (95.07–99.90) | 98.21 (92.83–99.56) | 0.6§ |
Symptoms | 58 | 12 | 96.55 (86.91–99.13) | 96.55 (86.91–99.13) | 92.80 (81.92–97.24) | |
Cumulative incidence of CF-related death¶ | ||||||
Severe | ||||||
NBS | 95 | 13 | 1.16 (0.17–8.16) | 6.22 (2.66–14.55) | 12.36 (6.66–22.92) | 0.0001ƒ |
Symptoms | 34 | 19 | 12.12 (4.84–30.38) | 27.27 (15.62–47.61) | 36.36 (23.16–57.11) | |
Moderate | ||||||
NBS | 80 | 3 | 0.00 | 0.00 | 3.98 (1.02–15.48) | 0.01ƒ |
Symptoms | 40 | 10 | 0.00 | 11.11 (4.41–27.99) | 14.07 (6.24–31.75) | |
Mild | ||||||
NBS | 149 | 4 | 0.71 (0.10–5.00) | 0.71 (0.10–5.00) | 1.79 (0.44–7.28) | 0.2ƒ |
Symptoms | 58 | 9 | 3.45 (0.88–13.46) | 3.45 (0.88–13.46) | 7.20 (2.80–18.53) | |
Event-free survival+ | ||||||
Severe | ||||||
NBS | 95 | 33 | 98.84 (92.03–99.84) | 88.68 (79.34–93.95) | 79.76 (68.53–87.33) | 0.07§ |
Symptoms | 34 | 25 | 87.88 (70.86–95.27) | 72.73 (54.13–84.77) | 63.64 (44.95–77.46) | |
Moderate | ||||||
NBS | 80 | 6 | 100.00 | 98.46 (89.58–99.78) | 92.68 (81.55–97.21) | 0.013§ |
Symptoms | 40 | 15 | 100.00 | 88.89 (73.05–95.68) | 85.93 (69.41–93.89) | |
Mild | ||||||
NBS | 149 | 8 | 99.29 (95.07–99.90) | 99.29 (95.07–99.90) | 95.78 (88.94–98.43) | 0.8§ |
Symptoms | 58 | 14 | 96.55 (86.91–99.13) | 96.55 (86.91–99.13) | 92.80 (81.92–97.24) |
Data are presented as n, unless otherwise stated. NBS: newborn screening. #: death due to any cause is considered an event; ¶: CF-related death is considered an event; +: death due to any cause and lung transplant were considered events; §: log-rank test; ƒ: Gray test.